Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04261855
Title Targeted Therapy and Avelumab in Merkel Cell Carcinoma (GoTHAM)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Melanoma and Skin Cancer Trials Limited
Indications

Merkel cell carcinoma

Therapies

Avelumab

Avelumab + lutetium Lu 177 dotatate

Age Groups: senior | adult
Covered Countries


No variant requirements are available.